Literature DB >> 12554774

Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor.

Ellis R Levin1.   

Abstract

Interactions between the estrogen receptor (ER) and the epidermal growth factor receptor (EGFR) contribute to the biological effects of these binding protein families. EGFR stimulates DNA synthesis and gene transcription in the uterus, related in part to estrogen-independent activation of the nuclear ER. This results from signal transduction enacted by the plasma membrane tyrosine kinase growth factor receptor, leading to 1) phosphorylation and activation of the nuclear ER, and 2) phosphorylation of coregulator proteins. More recently, it has been shown that a pool of ERalpha resides in or associates with the plasma membrane as a cytoplasmic protein. These ERs utilize the membrane EGFR to rapidly signal through various kinase cascades that influence both transcriptional and nontranscriptional actions of estrogen in breast cancer cells. This is congruent with a general theme of receptor signaling, where membrane G protein-coupled receptors activate tyrosine kinase growth factor receptors (EGFR, IGF-I receptor) that subsequently signal to MAPKs and other pathways. Overall, the bidirectional cross-talk between EGFR and cellular pools of ER contributes to reproductive organ physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12554774     DOI: 10.1210/me.2002-0368

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  98 in total

Review 1.  The role of the epidermal growth factor receptor in breast cancer.

Authors:  Samuel K Chan; Mark E Hill; William J Gullick
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

2.  Estrogen regulates epithelial cell deformability by modulation of cortical actomyosin through phosphorylation of nonmuscle myosin heavy-chain II-B filaments.

Authors:  Xin Li; Lingying Zhou; George I Gorodeski
Journal:  Endocrinology       Date:  2006-08-10       Impact factor: 4.736

3.  Epigenetic Reactivation of Estrogen Receptor: Promising Tools for Restoring Response to Endocrine Therapy.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  Mol Cell Pharmacol       Date:  2010

4.  Estrogen receptor expression in sporadic vestibular schwannomas.

Authors:  Carrie M Brown; Zana K Ahmad; Allen F Ryan; Joni K Doherty
Journal:  Otol Neurotol       Date:  2011-01       Impact factor: 2.311

5.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

Review 6.  Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.

Authors:  Hideki Kawai
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.

Authors:  Wai-Sum Lau; Wen-Fang Chen; Robbie Yat-Kan Chan; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

Review 8.  Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

Authors:  Emily M Fox; Josefa Andrade; Margaret A Shupnik
Journal:  Steroids       Date:  2008-11-05       Impact factor: 2.668

9.  Invited commentary: the etiology of lung cancer in men compared with women.

Authors:  Anthony J Alberg; Kristin Wallace; Gerard A Silvestri; Malcolm V Brock
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

10.  Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.

Authors:  Nataliya N Bulayeva; Bahiru Gametchu; Cheryl S Watson
Journal:  Steroids       Date:  2004-03       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.